Singapore recalls three versions of diabetes drug metformin


LONDON (Bloomberg): Singapore health officials have recalled three of 46 versions of the diabetes drug metformin after finding amounts of a cancer-causing substance that was "above the acceptable level".

The recalled drugs had been sold locally for only a short time, and the risk to patients who had taken them is low, Singapore's Health Sciences Authority said in a statement.

Save 30% for ads-free and full access now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Metformin , Singapore , diabetes

Others Also Read


Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In